Commentary.

The article comments on the study which evaluates the effectiveness of citalopram or interpersonal psychotherapy and placebo or clinical management in managing major depression in patients with coronary artery disease. The author states that the data from the clinical trials are limited and does not reveal good evidences that suggest the best treatment strategies in treating depression in these patients. The author also encourages clinicians to find ways to treat depression in cardiac patients.